Return to content in this issue


Successful Infusion of Obinutuzumab by Desensitization: A Case of Anaphylactic Shock During Desensitization

Kim KW1, Chung S1, Lee S-Y1,2, Yoon S-S1, Kang H-R1,2,3

1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea
3Drug Safety Monitoring Center, Seoul National University Hospital, Seoul, Korea

J Investig Allergol Clin Immunol 2020; Vol 30(6) : 457-459
doi: 10.18176/jiaci.0581

Key words: Desensitization, Obinutuzumab, Adverse reaction, Anaphylaxis

Title Type Size
doi10.18176_jiaci.0581_material-suppl.pdf pdf 238.76 Kb